Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: A meta-analysis

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 501-510

  Nikolopoulos, Georgios K ^a   Tsantes, Argirios E ^b   Bagos, Pantelis G ^c   Travlou, Anthi ^b   Vaiopoulos, Georgios ^c  

^a Hellenic Centre for Infectious Diseases Control   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

C807T polymorphism; Ischemic stroke; ITGA2; Meta analysis; Platelet

Indexed keywords

ALPHA2 INTEGRIN; BETA1 INTEGRIN; COLLAGEN;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ADHESION;

ALLELES; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENE FREQUENCY; HUMANS; INTEGRIN ALPHA2; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 33846472607     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.04.002     Document Type: Article

References (41)

1. Clemetson K.J., and Clemetson J.M. Platelet collagen receptors. Thromb Haemost 86 (2001) 189-197
2. Baungartner H.R. Platelet interaction with collagen fibrils in flowing blood: I. Reaction of human platelets with alphachymotrypsin-digested subendothelium. Thromb Haemost 37 (1977) 1-16
3. Sixma J.J., van Zanten H., Huizinga E.G., van der Plas R.M., Verkley M., and Wu Y.P. Platelet adhesion to collagen: an update. Thromb Haemost 78 (1997) 434-438
4. Alberio L., and Dale G.L. Flow cytometric analysis of platelet activation by different collagen types present in the vessel wall. Br J Haematol 102 (1998) 1212-1218
5. Kunicki T.J., Kritzik M., Annis D.S., and Nugent D.J. Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89 (1997) 1939-1943
6. Corral J., Gonzalez-Conejero R., Rivera J., Ortuno F., Aparicio P., and Vicente V. Role of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function-effect in thromboembolic diseases. Thromb Haemost 81 (1999) 951-956
7. Kritzik M., Savage B., Nugent D.J., Santoso S., Ruggeri Z.M., and Kunicki T.J. Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92 (1998) 2382-2388
8. Akar N., Duman T., Akar E., Deda G., and Sipahi T. The α2 gene alleles of the platelet.collagen receptor integrin α2β1 in Turkish children with cerebral infarct. Thromb Res 102 (2001) 121-123
9. Carlsson L.E., Santoso S., Spitzer S., Kessler C., and Greinacher A. The α2 gene coding sequence T807/A873 of the platelet collagen receptor integrin α2β1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93 (1999) 3583-3586
10. Reiner A.P., Kumar P.N., Schwartz S.M., Longstreth Jr. W.T., Pearce R.M., Rosendaal F.R., et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31 (2000) 1628-1633
11. Cole V.J., Staton J.M., Eikelboom J.W., Hankey G.J., Yi Q., Shen Y., et al. Collagen platelet receptor polymorphisms integrin α2β1 C807T and GPVI Q317L and risk of ischemic stroke. J Thromb Haemost 1 (2003) 963-970
12. A1/A2 polymorphisms and ischemic stroke in young Taiwanese. J Neurol Sci 227 (2004) 1-5
13. Sacchi E., Tagliabue L., Duca F., Landi G., Merlini P.A., and Mannucci P.M. A C807T substitution in the platelet collagen receptor integrin α2β1 gene is a genetic risk factor for stroke at a young age but not for myocardial infarction. Haematologica 85 (2000) 10-11 [Abstract]
14. World Health Organization. The world health report: reducing risks, promoting healthy life (2002), World Health Organization, Genova
15. Petiti D.B. Meta-analysis decision analysis and cost-effectiveness analysis (2000), Oxford University Press, New York 115-116
16. Galbraith R.F. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7 (1988) 889-894
17. Berman N.G., and Parker R.A. Meta-analysis: neither quick nor easy. BMC Med Res Methodol 2 (2002) 10
18. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
19. Thompson S.G., and Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18 (1999) 2693-2708
20. Shapiro S.S., and Wilk M.B. An analysis of variance test for normality (complete samples). Biometrica 61 (1965) 644-646
21. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
22. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
23. Lau J., Antman E.M., Jimenez-Silva J., Kupelnick B., Mosteller F., and Chalmers T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327 (1992) 248-254
24. Carlsson L.E., Santoso S., Spitzer C., Eichler P., Kessler C., and Greinacher A. The impact of the GPIa/IIa -C807T polymorphism in patients with stroke and HIT-patients. Transfus Med 8 (1998) 260
25. Sacchi E., Tagliabue L., Duca F., Landi G., Merlini P.A., and Mannucci P.M. AC807T substitution in the platelet collagen receptor integrin α2β1 gene is a genetic risk factor for stroke in young patients. Thromb Haemost 82 (1999) 848 [abstract]
26. Margaglione M., D'Andera G., Giuliani N., Brancaccio V., De Lucia D., Grandone E., et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 19 (1999) 1751-1756
27. Mohanty S., Saxena R., and Behari M. Risk factors for thrombosis in non-embolic cerebrovascular disease. Am J Hematol 60 (1999) 239-241
28. Santoso S., Kunicki T.J., Kroll H., Haberbosch W., and Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 93 (1999) 2449-2453
29. Roest M., Banga J.D., Grobbee D.E., Groot P.G., Sixma J.J., Tempelmann M.J., et al. Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102 (2000) 1645-1650
30. Ioannidis J.P. Why most published research findings are false. PLoS Med 2 (2005) e124
31. Egger M., Ebrahim S., and Smith G.D. Where now for meta-analysis?. Int J Epidemiol 31 (2002) 1-5
32. Ioannidis J.P. Molecular bias. Eur J Epidemiol 20 (2005) 739-745
33. Thakkinstian A., McElduff P., D'Este C., Duffy D., and Attia J. A method for meta-analysis of molecular association studies. Stat Med 24 (2005) 1291-1306
34. Ioannidis J.P., and Trikalinos T.A. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 58 (2005) 543-549
35. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson D., Rennie D., et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 283 (2000) 2008-2012
36. Munafo M.R., and Flint J. Meta-analysis of genetic association studies. Trends Genet 20 (2004) 439-444
37. Attia J., Thakkinstian A., and D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56 (2003) 297-303
38. Minelli C., Thompson J.R., Abrams K.R., Thakkinstian A., and Attia J. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34 (2005) 1319-1328
39. Handa M., Watanabe K., Kawai Y., Kamata T., Koyama T., Nagai H., et al. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (α2β1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 73 (1995) 521
40. Kehrel B., Wierwille S., Clemetson K.J., Anders O., Steiner M., Knight C.G., et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 91 (1998) 491-499
41. Ye Z., Liu E.H., Higgins J.P., Keavney B.D., Lowe G.D., Collins R., et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367 (2006) 651-658